Arcus Biosciences, Inc. (RCUS) Net margin 2017–2025
Arcus Biosciences, Inc. (RCUS) net profit margin by fiscal year — reported net income divided by reported revenue.
-1069.7%FY2025 · since FY2017: -3756.7% → -1069.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1069.7% | -514.8 pp |
| FY2024 | -554.9% | +274.8 pp |
| FY2023 | -829.7% | -127.1 pp |
| FY2022 | -702.6% | -716.5 pp |
| FY2021 | 13.8% | +171.5 pp |
| FY2020 | -157.7% | +407.0 pp |
| FY2019 | -564.7% | +29.0 pp |
| FY2018 | -593.7% | +3163.0 pp |
| FY2017 | -3756.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice